.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Teva
Federal Trade Commission
Johnson and Johnson
Moodys
Fuji
Daiichi Sankyo
Harvard Business School
Covington

Generated: December 14, 2017

DrugPatentWatch Database Preview

Akorn Company Profile

« Back to Dashboard

What is the competitive landscape for AKORN, and what generic alternatives to AKORN drugs are available?

AKORN has one hundred and sixty-four approved drugs.

There is one US patent protecting AKORN drugs. There are three tentative approvals on AKORN drugs.

There are two patent family members on AKORN drugs in two countries and one hundred and forty supplementary protection certificates in twelve countries.

Summary for Akorn

International Patents:2
US Patents:1
Tradenames:131
Ingredients:120
NDAs:164
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Akorn IncNAPHAZOLINE HYDROCHLORIDEnaphazoline hydrochlorideSOLUTION/DROPS;OPHTHALMIC083590-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
AkornAMIODARONE HYDROCHLORIDEamiodarone hydrochlorideINJECTABLE;INJECTION076232-001Jul 5, 2006APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
AkornTROPICACYLtropicamideSOLUTION/DROPS;OPHTHALMIC040314-001Sep 29, 2000ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Akorn IncDOXERCALCIFEROLdoxercalciferolINJECTABLE;INJECTION203929-001May 7, 2015APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AkornERYTHROMYCINerythromycinOINTMENT;OPHTHALMIC064030-001Jul 18, 1996ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Akorn IncPILOCARPINE HYDROCHLORIDEpilocarpine hydrochlorideSOLUTION;OPHTHALMIC204398-002Sep 27, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AkornGENTAMICIN SULFATEgentamicin sulfateOINTMENT;OPHTHALMIC064093-001Aug 31, 1995ATRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
AkornTRANEXAMIC ACIDtranexamic acidINJECTABLE;INJECTION206594-001Sep 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AkornCAPASTAT SULFATEcapreomycin sulfateINJECTABLE;INJECTION050095-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Akorn IncMYCOPHENOLATE MOFETIL HYDROCHLORIDEmycophenolate mofetil hydrochlorideINJECTABLE;INJECTION204043-001Feb 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Akorn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AkornALFENTAalfentanil hydrochlorideINJECTABLE;INJECTION019353-001Dec 29, 1986► Subscribe► Subscribe
AkornSUFENTA PRESERVATIVE FREEsufentanil citrateINJECTABLE;INJECTION019050-001May 4, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Akorn Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2008014036► Subscribe
European Patent Office2043601► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Akorn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0032Belgium► SubscribePRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506
2015000111Germany► SubscribePRODUCT NAME: OKULARE IRRIGATIONSLOESUNG, WELCHE PHENYLEPHRIN ODER DESSEN PHARMAZEUTISCH WIRKSAMES SALZ UND KETOROLAC ODER DESSEN PHARMAZEUTISCH WIRKSAMES SALZ UMFASST; REGISTRATION NO/DATE: EU/1/15/1018 20150728
C0040France► SubscribePRODUCT NAME: OLOPATADINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/02/217/001 20020517
C/GB99/046United Kingdom► SubscribePRODUCT NAME: EPTIFIBATIDE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: CH 54054 19970227; CH 54050 19970227; UK EU/1/99/109/001 19990701; UK EU/1/99/109/002 19990701
2014 00050Denmark► SubscribePRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910
00117Netherlands► SubscribePRODUCT NAME: DEXMEDETOMIDINE, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH IN FARMACEUTISCH OPZICHT AANVAARDBAAR ZUURADDITIEZOUT, IN HET BIJZ ONDER DEXMEDETOMIDINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/2/02/033/001 20020830
2017 00030Denmark► SubscribePRODUCT NAME: IRINOTECAN SUCROSOFATE SALT, SUCH AS IRINOTECAN SUCROSOFATE SALT IN A PEGYLATED LIPOSOME, SUCH AS A LIPOSOME COMPRISING 1,2-DISTEAROYL-SN-PHOSPHATIDYLCHOLINE, CHOLESTEROL AND N-(OMEGA-METHOXY-POLY(ETHYLENE GLYCOL)...; REG. NO/DATE: EU/1 /16/1130 20161018
03C/005Belgium► SubscribePRODUCT NAME: CHLORHYDRATE DE DEXMEDETOMIDINE; REGISTRATION NO/DATE: EU/2/02/033/001 20020903
90043Netherlands► SubscribePRODUCT NAME: EPTIFIBATIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NAT. REGISTRATION NO/DATE: EU/1/99/109/001 - EU/1/99/109/002 19990701; FIRST REGISTRATION: CH 54050, 54054 19970227
C0012Belgium► SubscribePRODUCT NAME: AZELASTINE HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: 31 IS 113 F 13 19981021; FIRST REGISTRATION: GB PL 08336/0083 19980218
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Harvard Business School
Cerilliant
Teva
Farmers Insurance
Covington
Fuji
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot